Together, these data indicate that C3G is highly expressed in liver progenitor cells and immature hepatocytes, then down-regulated in adult hepatocytes and re-expressed in HCC, being progressively up-regulated during tumor progression, reaching a very high level at advanced stages. This evidence concerns the gene RAPGEF1 and hepatocellular carcinoma.